2026 ACC/AHA Dyslipidemia Guidelines

The 2026 American College of Cardiology (ACC) and American Heart Association (AHA) Dyslipidemia Guidelines provide the current clinical standard for managing abnormal lipid levels and reducing cardiovascular risk. They recommend strict LDL-C treatment goals based on risk-stratification, universal screening for lipoprotein-a, and the use of apolipoprotein-b for residual atherogenic risk assessment. The guidelines explicitly recommend against using unregulated dietary supplements like fish oils and red yeast rice.